Article

Minimization of free radical damage by metal catalysis of multivitamin/multimineral supplements

Research & Technology Development, Melaleuca Inc, Idaho Falls, ID 83402, USA.
Nutrition Journal (Impact Factor: 2.64). 11/2010; 9:61. DOI: 10.1186/1475-2891-9-61
Source: PubMed

ABSTRACT Multivitamin/multimineral complexes are the most common dietary supplements. Unlike minerals in foods that are incorporated in bioorganic structures, minerals in dietary supplements are typically in an inorganic form. These minerals can catalyze the generation of free radicals, thereby oxidizing antioxidants during digestion. Here we examine the ability of a matrix consisting of an amino acid and non-digestible oligosaccharide (AAOS) to blunt metal-catalyzed oxidations. Monitoring of ascorbate radical generated by copper shows that ascorbate is oxidized more slowly with the AAOS matrix than with copper sulfate. Measurement of the rate of oxidation of ascorbic acid and Trolox® by catalytic metals confirmed the ability of AAOS to slow these oxidations. Similar results were observed with iron-catalyzed formation of hydroxyl radicals. When compared to traditional forms of minerals used in supplements, we conclude that the oxidative loss of antioxidants in solution at physiological pH is much slower when AAOS is present.

Download full-text

Full-text

Available from: Garry R Buettner, Jul 04, 2015
0 Followers
 · 
99 Views
  • Source
    Oxidative Stress - Molecular Mechanisms and Biological Effects, 04/2012; , ISBN: 978-953-51-0554-1
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the present study was to investigate the status of oxidative stress in the serum of patients af-fected with cancer breast. Changes in the levels of total antioxidant capacity (TAC), uric acid, malon-dialdehyde (MDA), nitric oxide (nitrite/nitrate), cup-per and iron were measured in serum of patients af-fected by non-metastatic as well as metastatic cancer breast. Significant decrease in TAC (32.7% -37.5%), uric acid (28.1% -49.2%), MDA (20.7% -25.2%) and nitric oxide (50.4% -61.9%) were found in both groups of cancer breast patients compared to the control group. Serum Cu 2+ concentrations were sig-nificantly lower in metastatic cancer patient group compared with both control and non-metastatic can-cer groups. Fe 2+ in serum was significantly lower in patients with non-metastatic cancer compared to normal subjects and patients with metastatic cancer. Significant differences were also observed between patients with non-metastatic and metastatic cancer breast as regards serum uric acid and nitric oxide that were lower in metastatic compared with non-metastatic cancer breast.
    Open Journal of Molecular and Integrative Physiology 01/2011; 01(03). DOI:10.4236/ojmip.2011.13005
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKROUND: The aim of the present study was to assess the effects of zinc or copper and polyphenolic compounds on the 8-isoprostaglandin F2α concentration in the serum and urine of rats with mammary cancer (adenocarcinoma) induced with 7,12-dimethylbenz[a]antracene. The research focused on the kinetics of alterations in urinary 8-isoPGF2α at the early stage of carcinogenesis as well as the influence of dietary factors on the process. The impact of selected compounds on the intensity of DMBA--induced carcinogenesis was also assessed. RESULT AND CONCLUSIONS: Administration of DMBA, a compound that inducers mammary tumors in experimental animals, increased the serum and urinary 8-isoPGF2α levels in study rats. In the rat model, diet supplementation with zinc, combined with selected polyphenolic compounds (resveratrol or genistein) yielded a statistically significant decrease in the rat serum and urinary biomarker concentration with a simultaneously significant stimulation of carcinogenesis.The results indicate that there is an inverse correlation between the intensity of DMBA-induced carcinogenicity and the level of 8-isoPGF2α in urine and serum of rats.
    Lipids in Health and Disease 03/2011; 10:40. DOI:10.1186/1476-511X-10-40 · 2.31 Impact Factor